RESUMO
Visceral leishmaniasis (VL) is a chronic systemic disease. In Brazil this infection is caused by Leishmania (Leishmania) infantum. Extracellular vesicles (EVs) released by Leishmania species have different functions like the modulation of host immune systems and inflammatory responses, among others. This study evaluated the participation of EVs from L. (L.) infantum (Leish-EVs) in recognition of the humoral and cellular immune response of hosts with VL. Promastigotes were cultivated in 199 medium and, in the log phase of growth, they were centrifuged, washed, resus-pended in RPMI medium, and incubated for 2 to 24 h, at 25 °C or 37 °C to release Leish-EVs. This dynamic was evaluated using transmission (TEM) and scanning (SEM) electron microscopies, as well as nanoparticle tracking analysis (NTA). The results suggested that parasite penetration in mammal macrophages requires more Leish-EVs than those living in insect vectors, since promastigotes incubated at 37 °C released more Leish-EVs than those incubated at 25 °C. Infected THP-1 cells produced high EV concentration (THP-1 cells-EVs) when compared with those from the control group. The same results were obtained when THP-1 cells were treated with Leish-EVs or a crude Leishmania antigen. These data indicated that host-EV concentrations could be used to distinguish infected from uninfected hosts. THP-1 cells treated with Leish-EVs expressed more IL-12 than control THP-1 cells, but were unable to express IFN-γ. These same cells highly expressed IL-10, which inhibited TNF-α and IL-6. Equally, THP-1 cells treated with Leish-EVs up-expressed miR-21-5p and miR-146a-5p. In conclusion, THP-1 cells treated with Leish-EVs highly expressed miR-21-5p and miR-146a-5p and caused the dysregulation of IL-10. Indirectly, these results suggest that high expression of these miRNAs species is caused by Leish-EVs. Consequently, this molecular via can contribute to immunosuppression causing enhanced immunopathology in infected hosts.
RESUMO
Acute monocytic leukemia is a type of myeloid leukemia that develops in monocytes. The current clinical therapies for leukemia are unsatisfactory due to their side effects and nonspecificity toward target cells. Some lectins display antitumor activity and may specifically recognize cancer cells by binding to carbohydrate structures on their surface. Therefore, this study evaluated the response of the human monocytic leukemia cell lines THP-1 to the Olneya tesota PF2 lectin. The induction of apoptosis and reactive oxygen species production in PF2-treated cells was evaluated by flow cytometry, and the lectin-THP-1â cell interaction and mitochondrial membrane potential were evaluated by confocal fluorescence microscopy. PF2 genotoxicity was evaluated by DNA fragmentation analysis via gel electrophoresis. The results showed that PF2 binds to THP-1 cells, triggers apoptosis and DNA degradation, changes the mitochondrial membrane potential, and increases reactive oxygen species levels in PF2-treated THP-1 cells. These results suggest the potential use of PF2 for developing alternative anticancer treatments with enhanced specificity.
Assuntos
Lectinas , Leucemia Monocítica Aguda , Humanos , Lectinas/farmacologia , Lectinas/metabolismo , Leucemia Monocítica Aguda/tratamento farmacológico , Espécies Reativas de Oxigênio/metabolismo , Apoptose/fisiologia , Células THP-1RESUMO
Understanding macrophage biology can improve comprehension of diverse biological processes and provide insights into novel therapeutic immunomodulatory strategies. Due to limited yield and technical difficulty in isolating primary macrophages, in vitro studies commonly use monocytes as precursor cells. Monocytic cell lines are a virtually unlimited source of macrophage precursors and two of the most frequently used cell lines are THP-1 and U937. Besides a great variability in macrophage differentiation protocols there is scarce information on possible differences in the biological responses of these cell lines. In this study, we used a standardized differentiation protocol using PMA and compared the response of macrophages derived from THP-1 and U937 cells to M1-and M2-polarizing conditions. THP-1-derived macrophages are more responsive to M1 stimuli and skewed towards M1 phenotype, whereas U937-derived macrophages were more responsive to M2 stimuli and skewed towards M2 phenotype. THP-1-derived macrophages also had greater production of ROS and phagocytic activity. Under M1-polarizing conditions, macrophages derived from both THP-1 and U937 reduced phagocytosis activity and the increased production of ROS. This information should be considered to make an informed choice on the cell line used as in vitro macrophage model, according to the experimental goals and biological context.
RESUMO
Currently, the only available vaccine against tuberculosis is Mycobacterium bovis Bacille Calmette-Guérin (BCG). Pulmonary tuberculosis protection provided by the vaccine varies depending on the strain, the patient's age and the evaluated population. Although the adaptive immune responses induced by different BCG strains have been widely studied, little conclusive data is available regarding innate immune responses, especially in macrophages. Here, we aimed to characterize the innate immune responses of human THP-1-derived macrophages at the transcriptional level following a challenge with either the BCG Mexico (M.BCG) or Phipps (P.BCG) strains. After a brief in vitro characterization of the bacterial strains and the innate immune responses, including nitric oxide production and cytokine profiles, we analyzed the mRNA expression patterns and performed pathway enrichment analysis using RNA microarrays. Our results showed that multiple biological processes were enriched, especially those associated with innate inflammatory and antimicrobial responses, including tumor necrosis factor (TNF)-α, type I interferon (IFN-I) and IFN-γ. However, four DEGs were identified in macrophages infected with M.BCG compared to P. BCG. These findings indicated the proinflammatory stimulation of macrophages induced by both BCG strains, at the cytokine level and in terms of gene expression, suggesting a differential expression pattern of innate immune transcripts depending on the mycobacterial strain.
Assuntos
Vacina BCG , Mycobacterium bovis , Citocinas/metabolismo , Humanos , Imunidade Inata , Macrófagos/metabolismo , Fenótipo , RNA/metabolismoRESUMO
[This corrects the article DOI: 10.3389/fcimb.2022.826039.].
RESUMO
Visceral leishmaniasis caused by Leishmania (Leishmania) infantum in Latin America progress with hepatosplenomegaly, pancytopenia, hypergammaglobulinemia, and weight loss and maybe lethal mainly in untreated cases. miRNAs are important regulators of immune and inflammatory gene expression, but their mechanisms of action and their relationship to pathogenesis in leishmaniasis are not well understood. In the present study, we sought to quantify changes in miRNAs associated with immune and inflammatory pathways using the L. (L.) infantum promastigote infected- human monocytic THP-1 cell model and plasma from patients with visceral leishmaniasis. We identified differentially expressed miRNAs in infected THP-1 cells compared with non-infected cells using qPCR arrays. These miRNAs were submitted to in silico analysis, revealing targets within functional pathways associated with TGF-ß, chemokines, glucose metabolism, inflammation, apoptosis, and cell signaling. In parallel, we identified differentially expressed miRNAs in active visceral leishmaniasis patient plasma compared with endemic healthy controls. In silico analysis of these data indicated different predicted targets within the TGF-ß, TLR4, IGF-I, chemokine, and HIF1α pathways. Only a small number of miRNAs were commonly identified in these two datasets, notably with miR-548d-3p being up-regulated in both conditions. To evaluate the potential biological role of miR-548d-3p, we transiently transfected a miR-548d-3p inhibitor into L. (L.) infantum infected-THP-1 cells, finding that inhibition of miR-548d-3p enhanced parasite growth, likely mediated through reduced levels of MCP-1/CCL2 and nitric oxide production. Further work will be required to determine how miR-548d-3p plays a role in vivo and whether it serves as a potential biomarker of progressive leishmaniasis.
Assuntos
Leishmania infantum , Leishmaniose Visceral , MicroRNAs , Parasitos , Animais , Humanos , Leishmania infantum/genética , Macrófagos , MicroRNAs/genética , Parasitos/genéticaRESUMO
Propolis is a resinous mixture produced by bees from their secretions and plant material, so its composition varies depending on its botanical origin. Propolis has several beneficial bioactivities, but its skin sensitization properties have long been suspected. Nevertheless, the skin sensitization potency of Brazilian green propolis (BGP) has not been scientifically evaluated. Here, we used scientifically reliable tests to evaluate it. In vitro antigenicity test based on the human cell line activation test (OECD TG 442E) was performed by measuring the expression of CD54 and CD86, which are indicators of the antigenicity of test substances, on THP-1 and DC2.4 cells. BGP did not affect the expression of either marker on THP-1 cells, but upregulated the expression of CD86 on DC2.4 cells, suggesting that BGP may be a skin sensitizer. Then, we performed local lymph node assay (LLNA, OECD TG 429) as a definitive in vivo test. LLNA showed that 1.70% BGP primed skin sensitization and is a "moderate sensitizer". Our results indicate scientific proof of the validity of arbitrary concentrations (1-2%), which have been used empirically, and provide the first scientific information on the safe use of BGP.
Assuntos
Alérgenos , Dermatite Alérgica de Contato , Própole/farmacologia , Pele/efeitos dos fármacos , Animais , Brasil , Linhagem Celular , Feminino , Humanos , Ensaio Local de Linfonodo , Camundongos , Células THP-1RESUMO
American Tegumentary Leishmaniasis (ATL) is an endemic disease in Latin America, mainly caused in Brazil by Leishmania (Viannia) braziliensis. Clinical manifestations vary from mild, localized cutaneous leishmaniasis (CL) to aggressive mucosal disease. The host immune response strongly determines the outcome of infection and pattern of disease. However, the pathogenesis of ATL is not well understood, and host microRNAs (miRNAs) may have a role in this context. In the present study, miRNAs were quantified using qPCR arrays in human monocytic THP-1 cells infected in vitro with L. (V.) braziliensis promastigotes and in plasma from patients with ATL, focusing on inflammatory response-specific miRNAs. Patients with active or self-healed cutaneous leishmaniasis patients, with confirmed parasitological or immunological diagnosis, were compared with healthy controls. Computational target prediction of significantly-altered miRNAs from in vitro L. (V.) braziliensis-infected THP-1 cells revealed predicted targets involved in diverse pathways, including chemokine signaling, inflammatory, cellular proliferation, and tissue repair processes. In plasma, we observed distinct miRNA expression in patients with self-healed and active lesions compared with healthy controls. Some miRNAs dysregulated during THP-1 in vitro infection were also found in plasma from self-healed patients, including miR-548d-3p, which was upregulated in infected THP-1 cells and in plasma from self-healed patients. As miR-548d-3p was predicted to target the chemokine pathway and inflammation is a central to the pathogenesis of ATL, we evaluated the effect of transient transfection of a miR-548d-3p inhibitor on L. (V.) braziliensis infected-THP-1 cells. Inhibition of miR-548d-3p reduced parasite growth early after infection and increased production of MCP1/CCL2, RANTES/CCL5, and IP10/CXCL10. In plasma of self-healed patients, MCP1/CCL2, RANTES/CCL5, and IL-8/CXCL8 concentrations were significantly decreased and MIG/CXCL9 and IP-10/CXCL10 increased compared to patients with active disease. These data suggest that by modulating miRNAs, L. (V.) braziliensis may interfere with chemokine production and hence the inflammatory processes underpinning lesion resolution. Our data suggest miR-548d-3p could be further evaluated as a prognostic marker for ATL and/or as a host-directed therapeutic target.
Assuntos
Leishmania braziliensis , MicroRNAs , Parasitos , Animais , Brasil , Humanos , Inflamação , MicroRNAs/genéticaRESUMO
BACKGROUND: Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan able to infect humans and it is common in pregnant women. During pregnancy and lactation, there are changes in the concentration of 17ß-estradiol (E2), progesterone (Prg), and prolactin (PRL). It is known that a proinflamatory response reduces the susceptibility to be infected, and this response may change according to hormonal impairment. Monocytes and macrophages are the main barrier against many intracellular microorganisms, due to their ability to produce cytokines. The aim of this work was to determine the effect of E2, progesterone, and PRL on the infective capacity of T. gondii, proinflamatory immune response modulation and the expression of hormonal receptors on THP-1 cell stimulated with T. gondii. METHODS: The THP-1 cells were infected with 1500 T. gondii tachyzoites, of RH strain. Stimuli were conducted with recombinant PRL (200 ng/mL), E2 (40 nM) y Prg (40 nM). MTT assays were performed to evaluate cellular viability. Western blot assays were carried out to evaluate the expression of the hormonal receptors (PRLR, ERα, and ERß). Cytokines produced were measured with a magnetic bead kit directed to 17 cytokines. RESULTS: Stimuli with E2 and Prg increased T. gondii infection in monocytes after 48â¯h; however, no differences in infection were observed in PRL stimulus. The E2 decreased the secretion of IL-12 and IL-1ß and PRL did not modify the production of these cytokines in THP-1 cells stimulated with T. gondii; however, both hormones increased the production of IL-10. Besides, PRL augmented the production of IL-4 and IL-13. In contrast, Prg reduced these cytokines. Our results show that T. gondii induces the expression of ERα and ERß and lowers PRLR. The hormones modify the expression of the receptors of other hormones: Prg decreases PRLR, ERß and increases ERα; E2 diminishes PRLR; and PRL decreases ERα and ERß expression. CONCLUSION: The hormones can increase T. gondii infection and could be mediating an anti-inflammatory response in THP-1 cells. T. gondii induces changes in the expression of hormonal receptors.
Assuntos
Citocinas/metabolismo , Receptor alfa de Estrogênio/metabolismo , Receptor beta de Estrogênio/metabolismo , Receptores da Prolactina/metabolismo , Células THP-1/metabolismo , Toxoplasma/fisiologia , Animais , Corantes , Estradiol/metabolismo , Feminino , Humanos , Camundongos , Progesterona/metabolismo , Prolactina/metabolismo , Isoformas de Proteínas/metabolismo , Células THP-1/imunologia , Células THP-1/parasitologia , Sais de Tetrazólio , Tiazóis , Toxoplasma/crescimento & desenvolvimentoRESUMO
Toxoplasma gondii is able to infect a wide range of vertebrates, including humans. Studies show that cyclooxygenase-2 (COX-2) is a modulator of immune response in multiple types of infection, such as Trypanosoma cruzi. However, the role of COX-2 during T. gondii infection is still unclear. The aim of this study was to investigate the role of COX-2 during infection by moderately or highly virulent strains of T. gondii in Calomys callosus rodents and human THP-1 cells. C. callosus were infected with 50 cysts of T. gondii (ME49), treated with COX-2 inhibitors (meloxicam or celecoxib) and evaluated to check body weight and morbidity. After 40 days, brain and serum were collected for detection of T. gondii by real-time PCR and immunohistochemistry or cytokines by CBA. Furthermore, peritoneal macrophages or THP-1 cells, infected with RH strain or uninfected, were treated with meloxicam or celecoxib to evaluate the parasite proliferation by colorimetric assay and cytokine production by ELISA. Finally, in order to verify the role of prostaglandin E2 in COX-2 mechanism, THP-1 cells were infected, treated with meloxicam or celecoxib plus PGE2, and analyzed to parasite proliferation and cytokine production. The data showed that body weight and morbidity of the animals changed after infection by T. gondii, under both treatments. Immunohistochemistry and real-time PCR showed a reduction of T. gondii in brains of animals treated with both COX-2 inhibitors. Additionally, it was observed that both COX-2 inhibitors controlled the T. gondii proliferation in peritoneal macrophages and THP-1 cells, and the treatment with PGE2 restored the parasite growth in THP-1 cells blocked to COX-2. In the serum of Calomys, upregulation of pro-inflammatory cytokines was detected, while the supernatants of peritoneal macrophages and THP-1 cells demonstrated significant production of TNF and nitrite, or TNF, nitrite and MIF, respectively, under both COX-2 inhibitors. Finally, PGE2 treatment in THP-1 cells triggered downmodulation of pro-inflammatory mediators and upregulation of IL-8 and IL-10. Thus, COX-2 is an immune mediator involved in the susceptibility to T. gondii regardless of strain or cell types, since inhibition of this enzyme induced control of infection by upregulating important pro-inflammatory mediators against Toxoplasma.
RESUMO
Yacon (Smallanthus sonchifolius) originates from the Andean region and has spread across South America, Europe and Japan. In contrast with most roots, yacon stores its carbohydrates in fructooligosaccharides (FOS) and contains approximately 37% of FOS in its root dry matter. Aqueous extracts of yacon were characterized through TLC, methylation, NMR, and ESI-MS. FOS of yacon showed as linear fructooligosaccharides containing almost exclusively (2â1)-linked ß-fructofuranosyl units, with terminal α-glucopyranosyl and ß-fructofuranosyl units. ESI-MS analyses indicated a wide degree of polymerization (DP) ranging from 2 to 10. The effect of the isolated FOS on non-specific immune activity by THP-1 cells was evaluated through phagocytic activity against heat-killed yeast (Saccharomices cerevisiae). The stimulant effect of yacon FOS was dose- and time-dependent, showing results more effective than branched FOS observed in previous studies. The results reinforce the use of linear yacon FOS as immunomodulators.
Assuntos
Asteraceae/química , Ativação de Macrófagos/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Oligossacarídeos/isolamento & purificação , Oligossacarídeos/farmacologia , Saccharomyces cerevisiae/citologia , Adjuvantes Imunológicos/química , Adjuvantes Imunológicos/isolamento & purificação , Adjuvantes Imunológicos/farmacologia , Linhagem Celular , Humanos , Macrófagos/microbiologia , Oligossacarídeos/química , Fagocitose/efeitos dos fármacosRESUMO
Syzygium jambos is an Indo-Malaian found in many tropical countries and it is mainly composed of carbohydrates. Fraction PF-WSP and SF-WSP were obtained by aqueous extraction followed by Fehling's treatment. Monosaccharide analysis showed that fraction PF-WSP has a high content of uronic acids (90%) and fraction SF-WSP presented mainly galactose (39.1%) and arabinose (34.2%), as neutral sugars and 9% of galacturonic acid. The presence of type II arabinogalactan in SF-WSP was evidenced by methylation analysis and 13C/1H HSQC NMR experiments. Immunomodulating properties of SF-WSP was investigated. It decreases THP-1 macrophage viability at the highest concentration tested (200µg/mL). We then tested non-cytotoxic concentrations of SF-WSP on THP-1 cytokine production in the presence and absence of LPS. The results showed that SF-WSP increased TNF-α, IL-1ß and IL-10 secretion in a concentration-dependent manner as well as attenuated the inflammatory response induced by LPS at the highest concentration (100µg/mL). These results contribute to elucidate the effects of fruit pectic polysaccharides on immune cells.
Assuntos
Galactanos/química , Fatores Imunológicos/química , Extratos Vegetais/química , Syzygium/química , Arabinose/química , Carboidratos/química , Citocinas/genética , Citocinas/imunologia , Galactanos/isolamento & purificação , Galactanos/farmacologia , Galactose/química , Ácidos Hexurônicos/química , Humanos , Fatores Imunológicos/isolamento & purificação , Fatores Imunológicos/farmacologia , Monócitos/efeitos dos fármacos , Monócitos/imunologia , Ácidos Urônicos/químicaRESUMO
The Bacille Calmette-Guérin (BCG) vaccine comprises a family of genetically different strains derived by the loss of genomic regions (RDs) and other mutations. In BCG Moreau, loss of RD16 inactivates rv3405c * , encoding a transcriptional repressor that negatively regulates the expression of Rv3406, an alkyl sulfatase. To evaluate the impact of this loss on the BCG and host cell viability and the cytokine profile, THP-1 cells were infected with BCG Moreau (harbouring the empty vector) and a complemented strain carrying a functional copy of rv3405c. Viability of the host cells and bacteria as well as the pattern of cytokine secretion were evaluated. Our results show that the viability of BCG Moreau is higher than that of the complemented strain in an axenic medium, suggesting a possible functional gain associated with the constitutive expression of Rv3406. Viability of the host cells did not vary significantly between recombinant strains, but differences in the profiles of the cytokine secretion (IL-1β and IL-6) were observed. Our results suggest an example of a functional gain due to gene loss contributing to the elucidation of the impact of RD16 on the physiology of BCG Moreau.
Assuntos
Humanos , Transcrição Gênica/genética , Vacina BCG/farmacologia , Sobrevivência Celular/genética , Citocinas/efeitos dos fármacos , Mutação com Ganho de Função/genética , Macrófagos/microbiologia , Mycobacterium bovis/genética , Fatores de Tempo , Transcrição Gênica/efeitos dos fármacos , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/microbiologia , Vacina BCG/genética , Sobrevivência Celular/efeitos dos fármacos , Citocinas/genética , Mutação com Ganho de Função/efeitos dos fármacos , Mycobacterium bovis/fisiologiaRESUMO
Crotoxin (CTX), the major toxin of Crotalus durissus terrificus snake venom, induces immunomodulatory action, particularly on the macrophages function, crucial cells to innate defense mechanisms. In these cells, dual action of this toxin is observed, since both inhibition of some functional parameters such as spreading and phagocytosis, as well as respiratory burst (hydrogen peroxide-H2O2 generation and nitric oxide-NO generation), Lipoxin A4 (LXA4) and its stable analog (15-Epi-LXA4) secretion and glucose and glutamine metabolism increased. Recent studies have demonstrated the importance of these CTX stimulatory actions on the metabolism of macrophages for the control of infectious inflammatory response and for tumor progression. Furthermore, FPRs are crucial for the different effects of CTX on macrophage function and metabolism. In spite of these evidences, the mechanisms involved with the CTX stimulatory actions on the metabolism of these cells are not known in their entirety. Among the mechanisms involved in the regulation of energetic metabolism of macrophages, purinergic signaling is essential in the stimulation of cytokine secretion and the reactive oxygen species and reactive nitrogen species generation by macrophages, besides being receptors responsive to stimuli via FPRs. Therefore, the objective of the present project was to investigate the possible participation of purinergic receptors on the H2O2 production by CTX treated THP-1 monocytic cells and whether FPRs participate in this signaling. For this purpose, THP-1 cells were used, such as monocytes or macrophage-differentiated or LPS-stimulated cells. The results show that THP-1 monocytes, such as macrophages differentiated from THP-1, by previous incubation with PMA, showed a significant increase of H2O2 production in the presence of different concentrations of CTX. CTX-induced H2O2 production increased was also observed after 24 hours by differentiated and LPS-stimulated macrophages. Different CTX concentrations lead to a significant increase in the ATP releasing by THP-1, in the absence or presence of LPS. Furthermore, different concentrations of CTX enhanced visualization of P2Y11 purinergic receptors and FPRs in LPS-stimulated THP-1. Blocking of P2X and P2Y purinergic receptors by non-selective antagonists abolished CTX-induced H2O2 production. Blocking of the FPRs by the selective antagonist partially interfered with the production of this toxin-induced reaction. The results together demonstrate, in an unprecedented way, that human monocytes are responsive to the action stimulatory CTX on ROS production and release of ATP and demonstrate for the first time that purinergic receptors are involved in this CTX-stimulatory action, with the FPRs participation.
A Crotoxina (CTX), toxina majoritária do veneno de serpente Crotalus durissus terrificus (VCdt) acarreta ação imunomoduladora, particularmente sobre a funcionalidade de macrófagos, células fundamentais para os mecanismos da defesa inata. Nestas células, é observado o dualismo na ação desta toxina, uma vez que foi observada tanto inibição de alguns parâmetros funcionais, como espraiamento e fagocitose, quanto à estimulação do “burst” respiratório (da geração de peróxido de hidrogênio-H2O2 e óxido nítrico-NO), da secreção de lipoxina A4 (LXA4) e seu análogo estável (15-Epi-LXA4) e do metabolismo de glicose e glutamina. Estudos recentes vêm demonstrando a importância dessas ações estimulatórias da CTX sobre o metabolismo de macrófagos para o controle da resposta inflamatória infecciosa e para a progressão tumoral. Ainda, receptores para peptídeo formil (Formyl Peptide Receptors-FPRs), ligantes de LXA4/15-Epi-LXA4 são cruciais para os diferentes efeitos da CTX sobre função e metabolismo de macrófagos. Apesar dessas evidencias não são conhecidos, na sua totalidade, os mecanismos envolvidos com as ações estimulatórias da CTX sobre o metabolismo destas células. Dentre os mecanismos envolvidos na regulação do metabolismo energético de macrófagos, a sinalização purinérgica é essencial na estimulação de secreção de citocinas e na geração de espécies reativas do oxigênio e do nitrogênio por macrófagos, além de serem receptores responsivos a estímulos via FPRs. Portanto, o objetivo do presente projeto foi investigar a possível participação dos receptores purinérgicos (RPs) sobre a produção de H2O2 por células monocíticas da linhagem THP-1, tratadas com CTX e se FPRs participam desta sinalização. Para tanto, foram utilizadas as células THP-1, como monócitos ou diferenciados em macrófagos ou estimulados por LPS. Os resultados mostram que os monócitos THP-1, como macrófagos diferenciados a partir de THP-1, por meio da incubação prévia com PMA, apresentaram aumento significativo da produção de H2O2 na presença das diferentes concentrações de CTX. O aumento da produção de H2O2 induzido pela CTX também foi observado após 24 horas, por macrófagos diferenciados e estimulados com LPS. Diferentes concentrações de CTX acarretam importante aumento de liberação de ATP por THP-1, na ausência ou presença de LPS. Ainda, as diferentes concentrações de CTX induziram aumento da visualização de receptores purinérgicos P2Y11 e FPRs em THP-1 estimuladas com LPS. O bloqueio dos receptores purinérgicos P2X e P2Y por antagonistas não seletivos aboliu a produção de H2O2 induzida pela CTX. O bloqueio dos FPRs pelo antagonista seletivo interferiu parcialmente com a produção deste reativo induzido pela toxina. Os resultados em conjunto demonstram, de maneira inédita, que monócitos humanos são responsivos à ação estimulatória da CTX sobre a produção de ROS e liberação de ATP e demonstram, pela primeira vez, que receptores purinérgicos estão envolvidos nesta ação estimulatória da CTX, com a participação dos FPRs.
RESUMO
OBJECTIVES: Geopropolis (GEO) in combination with doxorubicin (DOX) reduced HEp-2 cells viability compared to GEO and DOX alone. A possible effect of this combination on the innate immunity could take place, and its effects were analysed on THP-1 cell - a human leukaemia monocytic cell line used as a model to study monocyte activity and macrophage activity, assessing cell viability, expression of cell markers and cytokine production. METHODS: THP-1 cells were incubated with GEO, DOX and their combination. Cell viability was assessed by MTT assay, cell markers expression by flow cytometry and cytokine production by ELISA. KEY FINDINGS: GEO + DOX did not affect cell viability. GEO alone or in combination increased TLR-4 and CD80 but not HLA-DR and TLR-2 expression. GEO stimulated TNF-α production while DOX alone or in combination did not affect it. GEO alone or in combination inhibited IL-6 production. CONCLUSIONS: GEO exerted a pro-inflammatory profile by increasing TLR-4 and CD80 expression and TNF-α production, favouring the activation of the immune/inflammatory response. GEO + DOX did not affect cell viability and presented an immunomodulatory action. Lower concentrations of DOX combined to GEO could be used in cancer patients, avoiding side effects and benefiting from the biological properties of GEO.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Abelhas , Doxorrubicina/farmacologia , Mediadores da Inflamação/metabolismo , Inflamação/prevenção & controle , Macrófagos/efeitos dos fármacos , Monócitos/efeitos dos fármacos , Própole/farmacologia , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/toxicidade , Antígeno B7-1 , Biomarcadores/metabolismo , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Doxorrubicina/toxicidade , Antígenos HLA-DR/metabolismo , Humanos , Inflamação/induzido quimicamente , Inflamação/imunologia , Inflamação/metabolismo , Mediadores da Inflamação/imunologia , Interleucina-6/metabolismo , Macrófagos/imunologia , Macrófagos/metabolismo , Monócitos/imunologia , Monócitos/metabolismo , Própole/toxicidade , Fatores de Tempo , Receptor 2 Toll-Like/metabolismo , Receptor 4 Toll-Like/metabolismo , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Leishmaniasis is an overlooked tropical disease affecting approximately 1 million people in several countries. Clinical manifestation depends on the interaction between Leishmania and the host's immune response. Currently available treatment options for leishmaniasis are limited and induce severe side effects. In this research, we tested nitro-heterocyclic compounds (BSF series) as a new alternative against Leishmania. Its activity was measured in Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes using MTT colorimetric assay. Additionally, we assessed the phosphatidylserine exposure by promastigotes, measured by flow cytometry, as well as nitric oxide production, measured by Griess' method. The nitro-heterocyclic compounds (BSF series) showed activity against L. (L.) infantum promastigotes, inducting the phosphatidylserine exposition by promastigotes, decreasing intracellular amastigotes and increasing oxide nitric production. The selectivity index was more prominent to Leishmania than to macrophages. Compared to amphotericin b, our compounds presented higher IC50, however the selectivity index was more specific to parasite than to amphotericin b. In conclusion, these nitro-heterocyclic compounds showed to be promising as an anti-Leishmania drug, in in vitro studies
Assuntos
Leishmania infantum/virologia , Compostos Heterocíclicos/uso terapêuticoRESUMO
Leishmaniasis is an overlooked tropical disease affecting approximately 1 million people in several countries. Clinical manifestation depends on the interaction between Leishmania and the host's immune response. Currently available treatment options for leishmaniasis are limited and induce severe side effects. In this research, we tested nitro-heterocyclic compounds (BSF series) as a new alternative against Leishmania. Its activity was measured in Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes using MTT colorimetric assay. Additionally, we assessed the phosphatidylserine exposure by promastigotes, measured by flow cytometry, as well as nitric oxide production, measured by Griess' method. The nitro-heterocyclic compounds (BSF series) showed activity against L. (L.) infantum promastigotes, inducting the phosphatidylserine exposition by promastigotes, decreasing intracellular amastigotes and increasing oxide nitric production. The selectivity index was more prominent to Leishmania than to macrophages. Compared to amphotericin b, our compounds presented higher IC50, however the selectivity index was more specific to parasite than to amphotericin b. In conclusion, these nitro-heterocyclic compounds showed to be promising as an anti-Leishmania drug, in in vitro studies.
Assuntos
Antiprotozoários/farmacologia , Compostos Heterocíclicos/farmacologia , Leishmania infantum/efeitos dos fármacos , Leishmaniose Visceral/tratamento farmacológico , Nitrocompostos/farmacologia , Antiprotozoários/química , Antiprotozoários/uso terapêutico , Apoptose , Linhagem Celular , Relação Dose-Resposta a Droga , Citometria de Fluxo , Compostos Heterocíclicos/química , Compostos Heterocíclicos/uso terapêutico , Humanos , Concentração Inibidora 50 , Leishmania infantum/crescimento & desenvolvimento , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Macrófagos/parasitologia , Monócitos/efeitos dos fármacos , Óxido Nítrico/metabolismo , Nitrocompostos/química , Nitrocompostos/uso terapêutico , Fosfatidilserinas/análiseRESUMO
BACKGROUND: Human amnion mesenchymal cells (hAMCs), isolated from the amniotic membrane of human placenta, are a unique population of mesenchymal stem cells. Recent studies demonstrated that hAMCs could inhibit the activities and functions of several immune cells. However, their effect on inflammatory macrophages is largely unknown. This study investigated the effect of hAMCs on expression of inflammatory cytokines and mitogen-activated protein kinases (MAPKs)/NF-kB pathway in human THP-1 macrophages induced by lipopolysaccharide (LPS). RESULTS: The levels of TNF-α and IL-1ß secreted by LPS- stimulated THP-1 cells were increased significantly compared with those in the control group. After co-culture with different numbers of hAMCs, the levels of TNF-α and IL-1ß in LPS-stimulated THP-1 cells were significantly reduced compared with the LPS group. The mRNA expression of TNF-α and IL-1ß were also markedly inhibited. Moreover, treating LPS-stimulated THP-1 cells with hAMCs supernatants could also suppress TNF-α and IL-1ß production in THP-1 cells. Important signaling pathways involved in the production of TNF-α and IL-1ß were affected by hAMCs co-culture: hAMCs remarkably suppressed NF-kB activation and down-regulated the phosphorylation of ERK and JNK in LPS- stimulated THP-1 cells. CONCLUSIONS: Human amnion mesenchymal cells inhibited the production of TNF-α and IL-1ß secreted by LPS-stimulated THP-1 cells, partly through the suppression of NF-kB activation and ERK and JNK phosphorylation.
Assuntos
Humanos , Lipopolissacarídeos/farmacologia , Fator de Necrose Tumoral alfa/biossíntese , Interleucina-1beta/biossíntese , Células-Tronco Mesenquimais/fisiologia , Âmnio/citologia , Macrófagos/metabolismo , Fator de Necrose Tumoral alfa/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Interleucina-1beta/efeitos dos fármacosRESUMO
A β2-glicoproteína I (β2GPI) é uma proteína de fase aguda, produzida principalmente no fígado e intestino. Os efeitos dessa proteína sobre células mononucleares foram investigados tanto em monócitos humanos de sangue periférico quanto em células promonocíticas humanas da linhagem celular ATCC THP-1. As correlações entre sua concentração plasmática e a intensidade da inflamação sistêmica foram avaliadas em humanos e em um modelo experimental de infecção sistêmica, em ratos. Nenhum efeito da β2GPI foi observado sobre a resposta oxidativa de monócitos de sangue periférico durante a fagocitose de zymosan opsonisado ou de S. aureus, analisada respectivamente por quimiluminescência amplificada por luminol ou por citometria de fluxo. A β2GPI estimulou a viabilidade celular e estimulou a diferenciação dos promonócitos. As células THP-1 tratadas com β2GPI apresentaram adesão aumentada a placas de cultura bem como expressão aumentada de CD54 e CD14. A suplementação com β2GPI foi suficiente para manter a proliferação das células THP-1 em cultura sem a adição de soro por 72h. Não houve correlações entre a concentração plasmática da β2GPI e indicadores clínicos da resposta inflamatória aguda em pacientes sépticos. A concentração da β2GPI não correlacionou com as concentrações plasmáticas de IL-8, SAA e PCR, que foram encontradas elevadas no sangue de pacientes com sepse. A variação da concentração plasmática de β2GPI foi um fenômeno muito precoce no modelo experimental de sepse e translocação bacteriana. Nas primeiras três horas após a indução da sepse endovenosa, a concentração plasmática de β2GPI diminuiu de forma dependente da intensidade de infecção. Sugere-se que efeitos muito precoces de compartimentalização associados ao sangue portal medeiem esta regulação. As concentrações mais baixas de β2GPI foram observadas nos animais expostos à translocação bacteriana através da mucosa intestinal, associada a uma condição inflamatória leve. A derivação da linfa preveniu...
The β2-glycoprotein I (β2GPI) is an acute phase protein, produced mainly in the liver and intestine. The effects of this protein upon mononuclear cells were investigated both in monocytes from human peripheral blood, and in the human promonocytic cells from the ATCC THP-1 cell line. The correlations between its plasma concentration and systemic inflammation intensity were evaluated in humans and in ad experimental model of systemic infection in rats. No β2GPI effects were observed upon the oxidative response of blood monocytes during the phagocytosis of opsonized zymosan or S. aureus as analysed by luminol amplified chemiluminescence and flow cytometry. β2GPI enhanced the cellular viability and stimulated the differentiation of the promonocytes. The THP-1 cells treated with β2GPI presented increased adhesion to the plastic of cell culture plates as well as increased expression of CD54 and CD14 antigens. The supplementation with β2GPI was sufficient to support the proliferation of THP-1 cells in serum free culture conditions for 72 h. There were no correlations between the β2GPI plasma concentration and clinical parameters of the acute inflammatory response in septic patients. The β2GPI concentrations didn't correlated with the plasma concentrations of IL-8, SAA and C reactive protein, despite these substances were found increased in the blood of patients with sepsis. The β2GPI plasma concentration response was a very early phenomenon in the experimental sepsis and bacterial translocation model. The β2GPI concentration decreased within the first 3h after endovenous sepsis induction, depending on the infection intensity. Very early compartment effects associated with the portal blood are suggested to mediate such regulation. The lowest β2GPI concentrations were found in the animals exposed to bacterial translocation through the intestinal mucosa, associated with a mild inflammatory condition. The lymph derivation completely prevented the plasma β2GPI decrease...